576. Burden of Pneumococcal Disease Due to Serotypes Covered by the 13-Valent and New Higher-Valent Pneumococcal Conjugate Vaccines in All Children and Children at Risk in the United States

BACKGROUND: Routine vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) in infants along with a catch-up option with PCV13/PPSV23 in children with underlying medical conditions (UMC) have considerably reduced invasive pneumococcal disease (IPD) and non-invasive pneumococcal disease (PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Liping, Cane, Alejandro D, Perdrizet, Johnna, Arguedas, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752084/
http://dx.doi.org/10.1093/ofid/ofac492.628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752084/
http://dx.doi.org/10.1093/ofid/ofac492.628

Ejemplares similares